WHO Launches Ebola Treatment Trial in DRC Amid Outbreak

The World Health Organization (WHO) announced a trial for two antiviral drugs aimed at treating Ebola in the Democratic Republic of Congo (DRC). The trial was launched by WHO Director-General Tedros Adhanom Ghebreyesus and DRC's Health Minister Dr.

Samuel Roger Kamba. The current outbreak of Ebola in DRC began in May, with the situation declared a public health emergency due to the virus's high infectivity and the absence of approved vaccines or treatments.

As of July 1, there have been confirmed cases and deaths, including two fatalities in Uganda linked to the outbreak. The trial is being coordinated by scientists from the Institut National de Recherche Biomédicale in DRC, the Institut Tropical de Médecine in Belgium, and the University of Oxford in the UK.

The outbreak is currently restricted to three eastern provinces: South Kivu, North Kivu, and Ituri.